Clarkston Capital Partners LLC Acquires Shares of 348 UnitedHealth Group Incorporated (NYSE:UNH)

Clarkston Capital Partners LLC purchased a new stake in UnitedHealth Group Incorporated (NYSE:UNH) during the third quarter, according to its most recent disclosure with the SEC. The firm purchased 348 shares of the healthcare conglomerate’s stock, valued at approximately $203,000.

Several other large investors also recently bought and sold shares of the company. Kathleen S. Wright Associates Inc. purchased a new position in UnitedHealth Group in the 3rd quarter valued at $27,000. Macroview Investment Management LLC boosted its position in UnitedHealth Group by 671.4% during the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after acquiring an additional 47 shares during the last quarter. Bbjs Financial Advisors LLC acquired a new stake in UnitedHealth Group in the 2nd quarter valued at about $31,000. Global Wealth Strategies & Associates boosted its holdings in shares of UnitedHealth Group by 152.4% during the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after purchasing an additional 32 shares during the last quarter. Finally, Signature Resources Capital Management LLC increased its holdings in shares of UnitedHealth Group by 40.0% in the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock valued at $32,000 after purchasing an additional 18 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $592.23 on Monday. The business’s fifty day moving average price is $582.84 and its 200 day moving average price is $549.98. The firm has a market capitalization of $545.02 billion, a PE ratio of 38.58, a price-to-earnings-growth ratio of 1.74 and a beta of 0.58. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. The firm had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm’s quarterly revenue was up 9.2% compared to the same quarter last year. During the same period in the prior year, the company posted $6.56 earnings per share. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.42%. The ex-dividend date is Monday, December 9th. UnitedHealth Group’s dividend payout ratio is presently 54.72%.

Wall Street Analyst Weigh In

UNH has been the subject of a number of recent research reports. UBS Group cut their target price on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. Truist Financial reiterated a “buy” rating and issued a $625.00 target price (down from $640.00) on shares of UnitedHealth Group in a report on Wednesday, October 16th. Bank of America decreased their price objective on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. Morgan Stanley cut their target price on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. Finally, HSBC downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 17th. Three analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus price target of $615.53.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.